vs
ALLIENT INC（ALNT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
ALLIENT INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$143.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 17.5%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $11.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.2%）
Allient Inc是一家全球化技术制造企业，主营精密运动、控制及电源解决方案的设计、生产与分销，核心服务航空航天、国防、医疗设备、工业自动化、商用出行等领域，业务覆盖北美、欧洲及亚太地区。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ALNT vs PBYI — 直观对比
营收规模更大
ALNT
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出10.2%
17.5%
自由现金流更多
PBYI
多$2.7M
$11.7M
两年增速更快
PBYI
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.4M | $75.5M |
| 净利润 | $6.4M | — |
| 毛利率 | 32.4% | 69.3% |
| 营业利润率 | 7.9% | 22.7% |
| 净利率 | 4.5% | — |
| 营收同比 | 17.5% | 27.7% |
| 净利润同比 | 111.8% | — |
| 每股收益（稀释后） | $0.38 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALNTPBYI
| Q4 25 | $143.4M | $75.5M | ||
| Q3 25 | $138.7M | $54.5M | ||
| Q2 25 | $139.6M | $52.4M | ||
| Q1 25 | $132.8M | $46.0M | ||
| Q4 24 | $122.0M | $59.1M | ||
| Q3 24 | $125.2M | $80.5M | ||
| Q2 24 | $136.0M | $47.1M | ||
| Q1 24 | $146.7M | $43.8M |
净利润ALNTPBYI
| Q4 25 | $6.4M | — | ||
| Q3 25 | $6.5M | $8.8M | ||
| Q2 25 | $5.6M | $5.9M | ||
| Q1 25 | $3.6M | $3.0M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $2.1M | $20.3M | ||
| Q2 24 | $1.1M | $-4.5M | ||
| Q1 24 | $6.9M | $-4.8M |
毛利率ALNTPBYI
| Q4 25 | 32.4% | 69.3% | ||
| Q3 25 | 33.3% | 77.7% | ||
| Q2 25 | 33.2% | 76.5% | ||
| Q1 25 | 32.2% | 77.1% | ||
| Q4 24 | 31.5% | 76.4% | ||
| Q3 24 | 31.4% | 63.9% | ||
| Q2 24 | 29.9% | 77.4% | ||
| Q1 24 | 32.3% | 75.5% |
营业利润率ALNTPBYI
| Q4 25 | 7.9% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | 8.4% | 12.7% | ||
| Q1 25 | 6.6% | 8.7% | ||
| Q4 24 | 5.3% | 22.6% | ||
| Q3 24 | 5.3% | 27.4% | ||
| Q2 24 | 3.6% | -4.6% | ||
| Q1 24 | 8.2% | -5.3% |
净利率ALNTPBYI
| Q4 25 | 4.5% | — | ||
| Q3 25 | 4.7% | 16.2% | ||
| Q2 25 | 4.0% | 11.2% | ||
| Q1 25 | 2.7% | 6.5% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 1.7% | 25.2% | ||
| Q2 24 | 0.8% | -9.6% | ||
| Q1 24 | 4.7% | -11.0% |
每股收益（稀释后）ALNTPBYI
| Q4 25 | $0.38 | $0.26 | ||
| Q3 25 | $0.39 | $0.17 | ||
| Q2 25 | $0.34 | $0.12 | ||
| Q1 25 | $0.21 | $0.06 | ||
| Q4 24 | $0.17 | $0.40 | ||
| Q3 24 | $0.13 | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 | ||
| Q1 24 | $0.42 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $301.5M | $130.3M |
| 总资产 | $577.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ALNTPBYI
| Q4 25 | $40.7M | $97.5M | ||
| Q3 25 | $39.5M | $94.4M | ||
| Q2 25 | $49.9M | $96.0M | ||
| Q1 25 | $47.8M | $93.2M | ||
| Q4 24 | $36.1M | $101.0M | ||
| Q3 24 | $37.1M | $96.7M | ||
| Q2 24 | $31.3M | $96.8M | ||
| Q1 24 | $31.5M | $107.2M |
总债务ALNTPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ALNTPBYI
| Q4 25 | $301.5M | $130.3M | ||
| Q3 25 | $294.2M | $115.3M | ||
| Q2 25 | $289.1M | $104.7M | ||
| Q1 25 | $272.8M | $97.1M | ||
| Q4 24 | $264.9M | $92.1M | ||
| Q3 24 | $272.9M | $71.1M | ||
| Q2 24 | $265.7M | $48.5M | ||
| Q1 24 | $267.1M | $51.0M |
总资产ALNTPBYI
| Q4 25 | $577.6M | $216.3M | ||
| Q3 25 | $585.1M | $202.9M | ||
| Q2 25 | $588.1M | $194.9M | ||
| Q1 25 | $586.9M | $196.2M | ||
| Q4 24 | $575.8M | $213.3M | ||
| Q3 24 | $596.4M | $220.7M | ||
| Q2 24 | $595.8M | $205.0M | ||
| Q1 24 | $611.6M | $214.1M |
负债/权益比ALNTPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $11.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 8.1% | 19.1% |
| 资本支出强度资本支出/营收 | 1.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.12× | — |
| 过去12个月自由现金流最近4个季度 | $49.7M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ALNTPBYI
| Q4 25 | $13.6M | $14.4M | ||
| Q3 25 | $4.7M | $9.7M | ||
| Q2 25 | $24.5M | $14.1M | ||
| Q1 25 | $13.9M | $3.6M | ||
| Q4 24 | $12.4M | $15.6M | ||
| Q3 24 | $12.1M | $11.0M | ||
| Q2 24 | $8.2M | $1.0M | ||
| Q1 24 | $9.2M | $11.2M |
自由现金流ALNTPBYI
| Q4 25 | $11.7M | $14.4M | ||
| Q3 25 | $2.8M | $9.7M | ||
| Q2 25 | $22.4M | $14.1M | ||
| Q1 25 | $12.9M | $3.6M | ||
| Q4 24 | $9.6M | $15.6M | ||
| Q3 24 | $10.5M | $11.0M | ||
| Q2 24 | $5.8M | $1.0M | ||
| Q1 24 | $6.2M | — |
自由现金流率ALNTPBYI
| Q4 25 | 8.1% | 19.1% | ||
| Q3 25 | 2.0% | 17.7% | ||
| Q2 25 | 16.0% | 26.8% | ||
| Q1 25 | 9.7% | 7.7% | ||
| Q4 24 | 7.9% | 26.4% | ||
| Q3 24 | 8.4% | 13.7% | ||
| Q2 24 | 4.3% | 2.1% | ||
| Q1 24 | 4.2% | — |
资本支出强度ALNTPBYI
| Q4 25 | 1.3% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 1.5% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 2.3% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 2.0% | 0.0% |
现金转化率ALNTPBYI
| Q4 25 | 2.12× | — | ||
| Q3 25 | 0.72× | 1.10× | ||
| Q2 25 | 4.36× | 2.41× | ||
| Q1 25 | 3.92× | 1.21× | ||
| Q4 24 | 4.11× | — | ||
| Q3 24 | 5.75× | 0.54× | ||
| Q2 24 | 7.13× | — | ||
| Q1 24 | 1.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALNT
| Industrial And Electronics | $69.5M | 48% |
| Vehicle | $25.7M | 18% |
| Other | $20.9M | 15% |
| Aerospace And Defense | $20.6M | 14% |
| Distribution And Other Target Market | $6.7M | 5% |
PBYI
暂无分部数据
